Paclitaxel-Avelumab for Angiosarcoma

Clinical trial NCT03512834 · UNKNOWN

Trial details

NCT number: NCT03512834
Sponsor: Sung Yong Oh
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Angiosarcoma Metastatic

Start date: 2018-06-01
Primary completion: 2022-11-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.